BioXcel Therapeutics, Inc. (BTAI) › Total LiabilitiesBioXcel Therapeutics, Inc. (BTAI) — Total LiabilitiesAnnual figures by period end, from SEC filings.2017-12-31: $2.34M2018-12-31: $4.66M2019-12-31: $9.50M2020-12-31: $13.24M2021-12-31: $17.77M2022-12-31: $129.08M2023-12-31: $130.21M2024-12-31: $131.44M2025-12-31: $140.38M$140.38M2017-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$140.38M+6.8%2026-03-27Balance as of period end2024-12-31$131.44M+0.9%2026-03-27Balance as of period end2023-12-31$130.21M+0.9%2025-03-28Balance as of period end2022-12-31$129.08M+626.3%2024-03-22Balance as of period end2021-12-31$17.77M+34.2%2023-03-16Balance as of period end2020-12-31$13.24M+39.4%2022-03-11Balance as of period end2019-12-31$9.50M+103.8%2021-03-12Balance as of period end2018-12-31$4.66M+99.4%2020-03-09Balance as of period end2017-12-31$2.34M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)